SCHEMBL3574336

SCHEMBL3574336

CCOC(=O)C(OCCCc1ccccc1)C(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
NPC1 O15118 3/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
MAPT P10636 1/20 0.43
RAB9A P51151 2/20 0.43
RECQL P46063 1/20 0.43
ALOX5 P09917 1/20 0.42
TDP1 Q9NUW8 2/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
CTSK P43235 1/20 0.42
MMP8 P22894 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8330920 0.90 LMNA (0.53) LMNAPPARGPPARANPC1SMN1; SMN2
SCHEMBL8330922 0.87 PPARG (0.50) LMNAPPARGPPARANPC1SMN1; SMN2
SCHEMBL8331880 0.81 SMN1; SMN2 (0.50) LMNANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL11698031 0.79 LMNA (0.47) LMNANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL8331884 0.79 SMN1; SMN2 (0.48) LMNAPPARGPPARANPC1MEN1
SCHEMBL83075 0.78 TSHR (0.49) LMNASMN1; SMN2TDP1
SCHEMBL28877046 0.78 PPARG (0.47) PPARGPPARAMAPTMMP8
SCHEMBL1194007 0.77 TSHR (0.51) LMNA
Water SCHEMBL28127794 0.77 TSHR (0.47) LMNASMN1; SMN2
SCHEMBL12600910 0.77 HDAC8 (0.47) PPARGPPARANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741323-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-22 US disclosed
US-20070185109-A1 Idene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2007-08-09 US disclosed
EP-1740531-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Korea Research Institute of Chemical Technology (KR) 2007-01-10 EP disclosed
WO-2005100303-A1 INDENE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185109-A1 Idene derivatives and process for the preparation thereof INSR, PPARD, GPR119 LMNA 1323/4885PPARG 5/4885PPARA 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.